Lars-Olof Eriksson, Ph.D., MS.c. has been appointed vice president of PAREXEL’s Start-up and Accelerated Recruitment Team (START). Dr. Eriksson will lead a global team that provides strategic, comprehensive approach to accelerate study initiation and achieve last patient in (LPI) milestones for regional and international trials conducted for clients. “Approximately 45% of study delays are due to patient recruitment and enrollment issues. To help biopharmaceutical companies overcome thes...